imipramine has been researched along with albuterol in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (21.05) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 5 (26.32) | 29.6817 |
2010's | 7 (36.84) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Jouvent, R; Lecrubier, Y; Puech, AJ; Simon, HF; Widlocher, D | 1 |
Francès, H; Lecrubier, Y; Puech, AJ; Simon, P; Souto, M | 1 |
Bianchetti, A; Gonalons, N; Guitard, J; Keane, PE; Langlois, X; Le Fur, G; Martin, P; Simiand, J; Soubrié, P | 1 |
Greenshaw, AJ; McManus, DJ; Mousseau, DD; Paetsch, PR; Wishart, TB | 1 |
Assous, E; Duteil, J; Mangiameli, P; Pointeau, AM; Rambert, FA | 1 |
Belmaker, RH; Ebstein, RP; Lerer, B; Zohar, J | 1 |
Mogilnicka, E | 1 |
Dlaboga, D; Dziedzicka-Wasylewska, M; Góralska, M; Margas, W; Rogóz, Z | 1 |
Kusumoto, K; Nagao, T; Ogihara, T | 1 |
1 review(s) available for imipramine and albuterol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for imipramine and albuterol
Article | Year |
---|---|
[Study of a beta-adrenergic stimulant and its antidepressant activity in man].
Topics: Adrenergic Agonists; Albuterol; Animals; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depression; Dextroamphetamine; Drug Evaluation; Female; Humans; Imipramine; Isoproterenol; Male | 1977 |
17 other study(ies) available for imipramine and albuterol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Antagonism by d,1-propranolol of imipramine effects in mice.
Topics: Albuterol; Animals; Apomorphine; Body Temperature; Dextroamphetamine; Drug Interactions; Imipramine; Male; Mice; Oxotremorine; Propranolol; Reserpine; Yohimbine | 1979 |
Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Antidepressive Agents; Behavior, Animal; Body Temperature; Clenbuterol; Humans; Imipramine; In Vitro Techniques; Male; Mice; Motor Activity; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes | 1992 |
Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
Topics: Albuterol; Animals; Antidepressive Agents; Arousal; Brain; Desipramine; Dose-Response Relationship, Drug; Imipramine; Liver; Male; Monoamine Oxidase; Motor Activity; Norepinephrine; Phenelzine; Phenethylamines; Psychotropic Drugs; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Tranylcypromine | 1991 |
Flerobuterol: a potential antidepressant drug related to beta-adrenergic agonists. Experimental profile in mice.
Topics: Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Body Temperature; Drug Interactions; Hypothermia; Imipramine; Male; Mice; Motor Activity; Oxotremorine; Reserpine; Yohimbine | 1991 |
Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclase.
Topics: Adenylyl Cyclases; Adult; Aged; Albuterol; Animals; Bipolar Disorder; Cerebral Cortex; Cyclic AMP; Depressive Disorder; Female; Heart Rate; Humans; Imipramine; Lithium; Male; Middle Aged; Personality Inventory; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1982 |
The effects of acute and repeated treatment with salbutamol, a beta-adrenoceptor agonist, on clonidine-induced hypoactivity in rats.
Topics: Albuterol; Animals; Clonidine; Desipramine; Drug Interactions; Exploratory Behavior; Fluoxetine; Imipramine; Male; Propranolol; Rats; Rats, Inbred Strains; Yohimbine | 1982 |
Some behavioural effects of antidepressant drugs are time-dependent.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Antidepressive Agents; Cell Membrane; Cerebral Cortex; Citalopram; Clonidine; Drug Administration Schedule; Exploratory Behavior; Imipramine; Male; Motor Activity; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Receptors, Dopamine D2; Receptors, Dopamine D3; Synapses; Tetrahydronaphthalenes; Time Factors; Tritium | 2001 |
A new high-throughput analysis for drug metabolism profiling using liquid chromatography coupled with tandem mass spectrometry.
Topics: Acetaminophen; Albuterol; Biotransformation; Chromatography, Liquid; High-Throughput Screening Assays; Imipramine; Tandem Mass Spectrometry; Testosterone | 2013 |